108 related articles for article (PubMed ID: 24501734)
1. Anti-N-methyl-D-aspartate receptor encephalitis: a targeted review of clinical presentation, diagnosis, and approaches to psychopharmacologic management.
Kruse JL; Jeffrey JK; Davis MC; Dearlove J; IsHak WW; Brooks JO
Ann Clin Psychiatry; 2014 May; 26(2):111-9. PubMed ID: 24501734
[TBL] [Abstract][Full Text] [Related]
2. The relevance of anti-N-methyl-D-aspartate receptor encephalitis for psychiatrists.
Pavăl D; Gherghel-Pavăl N; Căpățînă OO; Stan A; Micluția IV
Int J Psychiatry Clin Pract; 2024 Mar; 28(1):73-81. PubMed ID: 38702981
[TBL] [Abstract][Full Text] [Related]
3. The psychopathology of NMDAR-antibody encephalitis in adults: a systematic review and phenotypic analysis of individual patient data.
Al-Diwani A; Handel A; Townsend L; Pollak T; Leite MI; Harrison PJ; Lennox BR; Okai D; Manohar SG; Irani SR
Lancet Psychiatry; 2019 Mar; 6(3):235-246. PubMed ID: 30765329
[TBL] [Abstract][Full Text] [Related]
4. Significant efficacy of electroconvulsive therapy on the behavioural symptoms of anti-N-methyl-d-aspartate receptor encephalitis.
Kim S; Horiuchi K; Ueda T; Boku S
BMJ Case Rep; 2024 Feb; 17(2):. PubMed ID: 38307623
[TBL] [Abstract][Full Text] [Related]
5. N-Methyl-D-Aspartate Receptor Encephalitis, Post Herpes Encephalitis in Two Pediatric Cases.
Al Futaisi A; Uraba WB; Al Dhawi N; Al Ajmi E; Al Kindi M; Al Shukaili J; Al Adi A
Oman Med J; 2023 Nov; 38(6):e578. PubMed ID: 38264516
[TBL] [Abstract][Full Text] [Related]
6. Psychiatric features of two cases of anti-nmdar autoimmune encephalitis.
Althoff BF; Sordi AO; Alves LPC; Telles LEB
Braz J Psychiatry; 2024; 46():e20233430. PubMed ID: 38252111
[No Abstract] [Full Text] [Related]
7. More than just anti-NMDAR: the many facets of autoimmune encephalitis.
Abdel Aziz K; Stip E; Arnone D
BJPsych Bull; 2021 Nov; 46(4):1-5. PubMed ID: 34842123
[TBL] [Abstract][Full Text] [Related]
8. Acute psychiatric symptoms in a young woman with anti-N-methyl D-aspartate receptor encephalitis: A case of successful early diagnosis and therapeutic intervention.
Tominaga M; Morikawa K; Yamamoto H; Ogawa Y; Kamimura N; Tsuneki I; Yahata T; Tamura M; Yanase T; Sato A; Shibuya H; Kurabayashi T
Clin Case Rep; 2022 Feb; 10(2):e05420. PubMed ID: 35154729
[TBL] [Abstract][Full Text] [Related]
9. Anti N-Methyl-D-Aspartate (NMDA) receptor encephalitis: from psychosis to cognitive impairment.
Vahabi Z; Etesam F; Zandifar A; Alizadeh F; Badrfam R
Clin Case Rep; 2021 Apr; 9(4):2174-2178. PubMed ID: 33936658
[TBL] [Abstract][Full Text] [Related]
10. Management of psychiatric symptoms in anti-NMDAR encephalitis: a case series, literature review and future directions.
Kuppuswamy PS; Takala CR; Sola CL
Gen Hosp Psychiatry; 2014; 36(4):388-91. PubMed ID: 24731834
[TBL] [Abstract][Full Text] [Related]
11. Anti-N-methyl-D-aspartate-receptor encephalitis: diagnosis, optimal management, and challenges.
Mann AP; Grebenciucova E; Lukas RV
Ther Clin Risk Manag; 2014; 10():517-25. PubMed ID: 25061311
[TBL] [Abstract][Full Text] [Related]
12. Anti-N-methyl-d-aspartate receptor encephalitis: review of clinical presentation, diagnosis and treatment.
Barry H; Byrne S; Barrett E; Murphy KC; Cotter DR
BJPsych Bull; 2015 Feb; 39(1):19-23. PubMed ID: 26191419
[TBL] [Abstract][Full Text] [Related]
13. Anti-NMDA receptor encephalitis, autoimmunity, and psychosis.
Kayser MS; Dalmau J
Schizophr Res; 2016 Sep; 176(1):36-40. PubMed ID: 25458857
[TBL] [Abstract][Full Text] [Related]
14. Autoimmune encephalitis as differential diagnosis of infectious encephalitis.
Armangue T; Leypoldt F; Dalmau J
Curr Opin Neurol; 2014 Jun; 27(3):361-8. PubMed ID: 24792345
[TBL] [Abstract][Full Text] [Related]
15. Ephrin-B2 prevents N-methyl-D-aspartate receptor antibody effects on memory and neuroplasticity.
Planagumà J; Haselmann H; Mannara F; Petit-Pedrol M; Grünewald B; Aguilar E; Röpke L; Martín-García E; Titulaer MJ; Jercog P; Graus F; Maldonado R; Geis C; Dalmau J
Ann Neurol; 2016 Sep; 80(3):388-400. PubMed ID: 27399303
[TBL] [Abstract][Full Text] [Related]
16. Anti-N-Methyl-D-Aspartate Receptor Encephalitis: A Review and Neuropsychological Case Study.
Loughan AR; Allen A; Perna R; Malkin MG
Clin Neuropsychol; 2016; 30(1):150-63. PubMed ID: 26998574
[TBL] [Abstract][Full Text] [Related]
17. All naturally occurring autoantibodies against the NMDA receptor subunit NR1 have pathogenic potential irrespective of epitope and immunoglobulin class.
Castillo-Gómez E; Oliveira B; Tapken D; Bertrand S; Klein-Schmidt C; Pan H; Zafeiriou P; Steiner J; Jurek B; Trippe R; Prüss H; Zimmermann WH; Bertrand D; Ehrenreich H; Hollmann M
Mol Psychiatry; 2017 Dec; 22(12):1776-1784. PubMed ID: 27502473
[TBL] [Abstract][Full Text] [Related]
18. Anti-Inflammatory Therapy and Immunotherapy Were Partially Effective in a Patient With Anti-N-Methyl-D-Aspartate Receptor Antibodies and a Special Subgroup of Treatment-Resistant Schizophrenia.
Senda M; Bessho K; Oshima E; Sakamoto S; Tanaka K; Tsutsui K; Kanbayashi T; Takaki M; Yoshimura B
J Clin Psychopharmacol; 2016 Feb; 36(1):92-3. PubMed ID: 26658265
[No Abstract] [Full Text] [Related]
19. Surface dynamics of GluN2B-NMDA receptors controls plasticity of maturing glutamate synapses.
Dupuis JP; Ladépêche L; Seth H; Bard L; Varela J; Mikasova L; Bouchet D; Rogemond V; Honnorat J; Hanse E; Groc L
EMBO J; 2014 Apr; 33(8):842-61. PubMed ID: 24591565
[TBL] [Abstract][Full Text] [Related]
20. Autoimmune epilepsies.
Bien CG; Bauer J
Neurotherapeutics; 2014 Apr; 11(2):311-8. PubMed ID: 24566940
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
